These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10425577)

  • 1. Treatment of metastatic glucagonoma to the liver: case report and literature review.
    Casadei R; Tomassetti P; Rossi C; la Donna M; Migliori M; Marrano D
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):308-12. PubMed ID: 10425577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic imaging of glucagonoma and transcatheter arterial embolization in hepatic metastases--report of a case].
    Shimizu T; Hirota S; Sako M; Ohtsuki S; Hasegawa M; Hanaguri K; Yamamoto M; Kadowaki S
    Rinsho Hoshasen; 1986 Mar; 31(3):433-6. PubMed ID: 3014183
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic glucagonoma: treatment with liver transplantation.
    Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
    J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintigraphic long-term follow-up of a patient with metastatic glucagonoma.
    Lipp RW; Schnedl WJ; Stauber R; Ranner G; Leb G; Krejs GJ
    Am J Gastroenterol; 2000 Jul; 95(7):1818-20. PubMed ID: 10925991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
    Nesović M; Cirić J; Radojković S; Zarković M; Durović M
    J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-time survival case of glucagonoma metastatic to the liver treated with TAE therapy].
    Fujimoto M; Ueda Y; Amari M; Moriyama H; Sakurai T; Okano H; Nagata M; Yokono K
    Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1329-31. PubMed ID: 10465984
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
    Krenning EP; Kooij PP; Bakker WH; Breeman WA; Postema PT; Kwekkeboom DJ; Oei HY; de Jong M; Visser TJ; Reijs AE
    Ann N Y Acad Sci; 1994 Sep; 733():496-506. PubMed ID: 7978900
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant glucagonoma. New options of treatment.
    Appetecchia M; Ferretti E; Carducci M; Izzo F; Carpanese L; Marandino F; Terzoli E
    J Exp Clin Cancer Res; 2006 Mar; 25(1):135-9. PubMed ID: 16761630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoembolization followed by systemic chemotherapy with dacarbazine for a metastatic glucagonoma].
    D'Alteroche L; Viguier J; Maillard H; Debbabi S; Certin M; Metman EH
    Gastroenterol Clin Biol; 2000 Jan; 24(1):132-3. PubMed ID: 10755862
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].
    Strohm WD
    Z Gastroenterol; 1996 Jul; 34(7):438-45. PubMed ID: 8928539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
    Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
    J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.
    Kimbara S; Fujiwara Y; Toyoda M; Chayahara N; Imamura Y; Kiyota N; Mukohara T; Fukunaga A; Oka M; Nishigori C; Minami H
    Clin J Gastroenterol; 2014 Jun; 7(3):255-9. PubMed ID: 26183746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic features of liver metastases from pancreatic glucagonoma and acinar cell carcinoma. Case reports.
    Ferrari A; Gavinelli M; Dominioni L; Carcano G; Dionigi R
    Surg Endosc; 1996 Jul; 10(7):762-4. PubMed ID: 8662436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
    Bouin M; Aoust LD
    Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic isolated liver perfusion with melphalan and bevacizumab.
    Voron T; Zinzindohoué F; Journois D; Hervé C; Ponzio O; Lucas N
    J Visc Surg; 2013 Feb; 150(1):60-6. PubMed ID: 23182850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonoma syndrome. Rapid response following arterial embolization of glucagonoma metastatic to the liver.
    Assaad SN; Carrasco CH; Vassilopoulou-Sellin R; Samaan NA
    Am J Med; 1987 Mar; 82(3):533-5. PubMed ID: 3030099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic glucagonoma presenting as a pulmonary mass.
    Pinto Marín A; Hernández Agudo E; Feliú J; González Barón M
    Clin Transl Oncol; 2009 Jan; 11(1):60-2. PubMed ID: 19155206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
    Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
    Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
    Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
    Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
    Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
    Med Oncol; 2007; 24(3):330-7. PubMed ID: 17873310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.